FDA Clearance Tracker · P010059-S001
ALCON REFORM CAPSULAR TENSION RING
Last checked: Nov 20, 2026Latest source record: Mar 15, 2004 (this decision)Source: openFDAMethods & limitations
Decided
Mar 15, 2004
Approved
Time to decision
55 days
Received Jan 20, 2004. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P010059-S001
- Device name
- ALCON REFORM CAPSULAR TENSION RING
- Applicant
- Morcher GmbH
- Applicant location
- Stuttgart
- Received
- Jan 20, 2004
- Decided
- Mar 15, 2004
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P010059
Device type
- Device type
- Ring, endocapsular (MRJ)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A PRIVATE LABEL DISTRIBUTOR AGREEMENT WITH ALCON LABORATORIES, INC., FORT WORTH, TEXAS. THE DEVICE WILL BE MARKETED UNDER THE TRADE NAME ALCON REFORM CAPSULAR TENSION RINGS (MODELS ACTR10, ACTR11, AND ACTR12).
Source documents
Other decisions for Morcher GmbH
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.